InvestorsObserver
×
News Home

Avenue Therapeutics Inc (ATXI) Stock Climbs 116.62% This Week; Should You Buy?

Tuesday, September 27, 2022 03:49 PM | InvestorsObserver Analysts

Mentioned in this article

Avenue Therapeutics Inc (ATXI) Stock Climbs 116.62% This Week; Should You Buy?

Avenue Therapeutics Inc (ATXI) stock has fallen -69.96% over the last 12 months. InvestorsObserver’s proprietary ranking system, gives ATXI stock a score of 21 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 0. ATXI's rank also includes a long-term technical score of 63.
Overall Score - 21
ATXI has an Overall Score of 21. Find out what this means to you and get the rest of the rankings on ATXI!

What's Happening with ATXI Stock Today

Avenue Therapeutics Inc (ATXI) stock is higher by 107.39% while the S&P 500 has fallen -0.29% as of 3:47 PM on Tuesday, Sep 27. ATXI is higher by $3.78 from the previous closing price of $3.52 on volume of 56,203,395 shares. Over the past year the S&P 500 is down -17.98% while ATXI has fallen -69.96%. ATXI lost -$4.00 per share in the over the last 12 months. Click Here to get the full Stock Report for Avenue Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App